Journal of Dermatological Treatment

Article	Citations
Minoxidil: a comprehensive review	58
Inpatient teledermatology during the COVID-19 pandemic	42
Guselkumab is efficacious and safe in psoriasis patients who failed anti-IL17: a 52-week real-life study	40
The danger of neglecting melanoma during the COVID-19 pandemic	38
Dupilumab in prurigo nodularis: a systematic review of current evidence and analysis of predictive factors to response	35
Melasma treatment: a systematic review	33
Dermatological consultations in the COVID-19 era: is teledermatology the key to social distancing? An Egyptian experience	31
Efficacy, safety, and drug survival of IL-23, IL-17, and TNF-alpha inhibitors for psoriasis treatment: a retrospective study	31
Guselkumab in moderate to severe psoriasis in routine clinical care: an Italian 44-week real-life experience	31
‘Loss of efficacy of topical 5% permethrin for treating scabies: an Austrian single-center study’	30
Short-term stress-related increasing cases of alopecia areata during the COVID-19 pandemic	29
The versatility of azelaic acid in dermatology	29
Topical finasteride for the treatment of male androgenetic alopecia and female pattern hair loss: a review of the current literature	27
Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia	26
COVID-19 and psoriasis: biologic treatment and challenges	26
Dupilumab for the treatment of adult atopic dermatitis in special populations	25
Safety of dupilumab in atopic patients during COVID-19 outbreak	25
A challenging case of psoriasis flare-up after COVID-19 infection	25
Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase	24
Continuous treatment with guselkumab maintains clinical responses through 4 years in patients with moderate-to-severe psoriasis: results from VOYAGE 1	24
Platelet-rich plasma as a therapy for androgenic alopecia: a systematic review and meta-analysis	24
The management of penile intraepithelial neoplasia (PeIN): clinical and histological features and treatment of 345 patients and a review of the literature	23
Biologics for patients affected by hidradenitis suppurativa in the COVID-19 era: data from a referral center of Southern Italy	23
Biologic treatment for psoriasis in cancer patients: should they still be considered forbidden?	22
Herpes zoster (shingles) complicating the course of COVID19 infection	22

Randomized trial of electrodynamic microneedling combined with 5% minoxidil topical solution for treating androgenetic alopecia in Chinese males and molecular mechanistic study of the involvement of t	21
JAK inhibitors in lichen planus: a review of pathogenesis and treatments	21
Beneficial effect of Lactobacillus plantarum IS-10506 supplementation in adults with atopic dermatitis: a randomized controlled trial	20
Antifungal resistance in superficial mycoses	20
Soluble biomarkers for diagnosis, monitoring, and therapeutic response assessment in psoriasis	20
Topical corticosteroid withdrawal (‘steroid addiction’): an update of a systematic review	19
Finasteride for hair loss: a review	19
Quantifying patient preferences for systemic atopic dermatitis treatments using a discrete-choice experiment	19
Biologic therapies for plaque type psoriasis in patients with previous malignant cancer: long-term safety in a single- center real-life population	19
Vehicles for atopic dermatitis therapies: more than just a placebo	19
The impact of COVID-19 pandemics on dermatologic surgery: real-life data from the Italian Red-Zone	18
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis	18
Human mesenchymal stem cell-derived exosomes accelerate wound healing of mice eczema	17
Network meta-analysis comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis	17
Review and analysis of biologic therapies currently in phase II and phase III clinical trials for atopic dermatitis	17
Efficacy of guselkumab versus secukinumab in subpopulations of patients with moderate-to-severe plaque psoriasis: results from the ECLIPSE study	17
A comparison of the efficacy and tolerability of three corticosteroid treatment regimens in patients with alopecia areata	17
Platelet-rich fibrin and concentrated growth factors as novel platelet concentrates for chronic hard-to-heal skin ulcers: a systematic review and Meta-analysis of randomized controlled trials	16
Risk of COVID-19 infection, hospitalization, and mortality in patients with psoriasis treated by interleukin-17 inhibitors	16
Disease burden and treatment history among adults with atopic dermatitis receiving systemic therapy: baseline characteristics of participants on the EUROSTAD prospective observational study	16
COVID-19 related anagen effluvium	15
Comparison of anti-TNF and IL-inhibitors treatments in patients with psoriasis in terms of response to routine laboratory parameter dynamics	15
The prevention effect of probiotics against eczema in children: an update systematic review and meta-analysis	15
Personalized irradiation therapy for NMSC by rhenium-188 skin cancer therapy: a long-term retrospective study	15
Comparative study between topical tranexamic acid alone versus its combination with autologous platelet rich plasma for treatment of melasma	15
Safety of baricitinib for the treatment of atopic dermatitis over a median of 1.6 years and up to 3.9 years of treatment: an updated integrated analysis of eight clinical trials	15
Elevation of peripheral blood eosinophils during dupilumab treatment for atopic dermatitis is associated with baseline comorbidities and development of facial redness dermatitis and ocular surface dis	15
Mucous membrane pemphigoid and COVID-19 treated with high-dose intravenous immunoglobulins: a case report	14
PASI 100 response rates in moderate to severe psoriasis: a systematic literature review and analysis of clinical practice guidelines	14
Conducting clinical trials during the COVID-19 pandemic	14
Mometasone furoate-loaded aspasomal gel for topical treatment of psoriasis: formulation, optimization, in vitro and in vivo performance	14
A survey of psoriasis patients on biologics during COVID-19: a single centre experience	14
Rituximab in childhood and juvenile autoimmune bullous diseases as first-line and second-line treatment: a case series of 13 patients	14
Dupilumab provides rapid and sustained improvement in SCORAD outcomes in adults with moderate-to-severe atopic dermatitis: combined results of four randomized phase 3 trials	14
The impact of COVID-19 pandemic on psoriasis patients, and their immunosuppressive treatment: a cross-sectional multicenter study from Turkey	13
Laboratory safety of dupilumab for up to 3 years in adults with moderate-to-severe atopic dermatitis: results from an open-label extension study	13
Topical methotrexate in dermatology: a review of the literature	13
Cosmetic skin lightening use and side effects	13
Generalized pustular psoriasis: the new era of treatment with IL-36 receptor inhibitors	13
The impact of COVID-19 pandemic in a cohort of Italian psoriatic patients treated with biological therapies	13
Low- dose systemic steroids, an emerging therapeutic option for COVID-19 related urticaria	12
Glucagon-like peptide-1 receptor agonist liraglutide therapy for psoriasis patients with type 2 diabetes: a randomized-controlled trial	12
The reduction in the detection of melanoma during the coronavirus disease 2019 (COVID-19) pandemic in a melanoma center of South Italy	12
Artificial intelligence image recognition of melanoma and basal cell carcinoma in racially diverse populations	12
Antihistamines-refractory chronic pruritus in psoriatic patients undergoing biologics: aprepitant vs antihistamine double dosage, a real-world data	11
Treating hidradenitis suppurativa during the COVID-19 pandemic: teledermatology exams of sensitive body areas	11
A case of severe psoriatic erythroderma with COVID-19	11
Psoriasis in difficult to treat areas: treatment role in improving health-related quality of life and perception of the disease stigma	11
A systematic review of antipsychotic agents for primary delusional infestation	11
Successful treatment of the face post acne erythema using a topically applied selective alpha 1-Adrenergic receptor agonist, oxymetazoline 1.5%, a controlled left to right face comparative trial	11

Effectiveness of benzyl benzoate treatment on clinical symptoms and Demodex density over time in patients with rosacea and demodicosis: a real life retrospective follow-up study comparing low- and hig	11
Are skin equipment for assessing childhood eczema any good?	11
Combined microneedling with topical application of platelet-rich plasma versus microneedling alone in the treatment of stria distensae: clinicopathological analysis	11
Ustekinumab as adjuvant treatment for all pyoderma gangrenosum subtypes	11
Onychomycosis in children – review on treatment and management strategies	11
Treatment adherence and persistence of seven commonly prescribed biologics for moderate to severe psoriasis and psoriatic arthritis in a U.S. commercially insured population	11
A novel plant-derived compound is synergistic with 5-fluorouracil and has increased apoptotic activity through autophagy in the treatment of actinic keratoses	11
COVID-19 in pemphigus vulgaris patients with previous rituximab therapy: a tele-medicine experience	11
Guselkumab, tildrakizumab, and risankizumab in a real-world setting: drug survival and effectiveness in the treatment of psoriasis and psoriatic arthritis	11
Psychological teleconsultations in patients suffering from chronic skin diseases during the COVID-19 era: a service to improve patients’ quality of life	10
Treatment of keratosis pilaris and its variants: a systematic review	10
Baricitinib for the treatment of atopic dermatitis	10
Cost per responder analysis of guselkumab versus targeted therapies in the treatment of moderate to severe plaque psoriasis in Germany	10
Pregnancy outcomes in patients with psoriasis, psoriatic arthritis, or axial spondyloarthritis receiving ixekizumab	10
The efficacy of rituximab in patients with mucous membrane pemphigoid	10
Dupilumab as promising treatment for prurigo nodularis: current evidences	10
Upadacitinib for the treatment of concomitant psoriasis and atopic dermatitis: a case series	10
New-onset and flares of psoriasis after COVID-19 infection or vaccination successfully treated with biologics: a case series	10
Bullous pemphigoid induced by biologic drugs in psoriasis: a systematic review	10
Treatment of patients with chronic pruritus of unknown origin with dupilumab	10
Efficacy of GLP-1rA, liraglutide, in plaque psoriasis treatment with type 2 diabetes: a systematic review and meta-analysis of prospective cohort and before-after studies	10
Egyptian dermatologists attitude toward telemedicine amidst the COVID19 pandemic: a cross-sectional study	10
Real-life experience with chlormethine gel for early-stage mycosis fungoides with emphasis on types and management of cutaneous side-effects#	10
Assessment of various intralesional injections in keloid: comparative analysis	10
Efficacy of curcumin for recurrent aphthous stomatitis: a systematic review	9
Successful treatment of paediatric generalized pustular psoriasis with secukinumab: a case series	9
A consistent skin care regimen leads to objective and subjective improvements in dry human skin: investigator-blinded randomized clinical trial	9
Treatment of acne vulgaris using 1,565 nm non-ablative fractional laser in combination with isotretinoin and pricking blood therapy	9
Cutaneous adverse events of immune checkpoint inhibitor therapy: incidence and types of reactive dermatoses	9
The differential effects of upadacitinib treatment on skin rashes of four anatomical sites in patients with atopic dermatitis	9
A comprehensive review of platelet-rich plasma for the treatment of dermatologic disorders	9
The effect of oral isotretinoin therapy on meibomian gland morphology and dry eye tests	9
Racial and ethnic diversity of US participants in clinical trials for acne, atopic dermatitis, and psoriasis: a comprehensive review	9
Tralokinumab rapidly improves subjective symptoms and quality of life in patients with moderate-to-severe atopic dermatitis: a real-life 16-week experience	9
The dark side of the moon: the immune-mediated adverse events of IL-17A/IL-17R inhibition	9
Systematic literature review of long-term efficacy data for topical psoriasis treatments	9
Psoriasis and risk of the COVID-19: is there a role for angiotensin converting enzyme (ACE)?	9
Severe chronic spontaneous urticaria in children – treatment options according to the guidelines and beyond – a 10 years review	9
Dermoscopic evaluation of tranexamic acid versus Vitamin C, with microneedling in the treatment of melasma: a comparative, split-face, single-blinded study	9
Elderly patients with psoriasis: long-term efficacy and safety of modern treatments	9
Dietary habits and perceptions of psoriatic patients: Mediterranean versus Asian diets	9
Emerging treatments for bullous pemphigoid	9
Evidence and potential mechanisms of traditional Chinese medicine for the treatment of psoriasis vulgaris: a systematic review and meta-analysis	9
Cognitive behavioral therapy as an adjuvant therapy in acne excoriée: a randomized controlled clinical trial	8
Dupilumab for the treatment of atopic dermatitis: real-world data from the Czech Republic BIOREP registry	8
Effect of oral administration of Triphala, a polyphenol-rich prebiotic, on scalp sebum in patients with scalp seborrhea a randomized clinical trial	8
Biologics recommendations for patients with psoriasis: a critical appraisal of clinical practice guidelines for psoriasis	8
Pain management modalities for hidradenitis suppurativa: a patient survey	8
Effectiveness of risankizumab in plaque psoriasis with involvement of difficult-to-treat areas: a real-world experience from two referral centers	8
Multidisciplinary management of chronic atopic dermatitis in children and adolescents: a prospective pilot study	8
Emerging topical therapies to treat pigmentary disorders: an evidence-based approach	8
A prospective, split-face study comparing 1,064-nm picosecond Nd:YAG laser toning with 1,064-nm Q-switched Nd:YAG laser toning in the treatment of melasma	8
Herpes zoster cases increased during COVID-19 outbreak. Is it possible a relation?	8
The prevalence of SARS-CoV-2 infection and the severity of the course of COVID-19 in patients with psoriasis treated with biologic therapy	8
Platelet-rich plasma for genital lichen sclerosus: analysis and results of 94 patients. Are there gender-related differences in symptoms and therapeutic response to PRP?	8
Patient and caregiver preferences on treatment attributes for atopic dermatitis	8
The effect of multistrain synbiotic and vitamin D3 supplements on the severity of atopic dermatitis among infants under 1 year of age: a double-blind, randomized clinical trial study	8
Improvement in sleep and itch and enhanced quality of life in adult patients with moderate-to-severe atopic dermatitis: results from a phase 3 trial of baricitinib therapy	8
Efficacy and predictive factors of cyclosporine A in alopecia areata: a systematic review with meta-analysis	8
Therapeutic outcome of diphencyprone and its correlation with serum cytokine profile in alopecia areata	8
Effectiveness of ustekinumab for moderate-to-severe hidradenitis suppurativa: a case series	8
Lack of reactivation of tuberculosis in patients with psoriasis treated with secukinumab in a real-world setting of latent tuberculosis infection	8
Predictors of drug survival of biologic therapies in psoriasis patients	8
Dupilumab for atopic dermatitis: a real-world Portuguese multicenter retrospective study	8
Fractional CO2-assisted photodynamic therapy improves the clinical outcome and patient’s satisfaction in toenail onychomycosis treatment: an intra-patient comparative single-center study	8
Dermatologists on the medical need for therapeutic drug monitoring of biologics in psoriasis: results of a structured survey	8
Proposition of standardized protocol for photodynamic therapy for vulvar lichen sclerosus	8
Pulsed dye laser versus intense pulsed light for facial erythema of rosacea: a systematic review and meta-analysis	7
Fractional erbium:YAG laser (2940 nm) plus topical hydroquinone compared to intradermal tranexamic acid plus topical hydroquinone for the treatment of refractory melasma: a randomized controlled trial	7
Spotlight on the treatment armamentarium of concomitant psoriasis and inflammatory bowel disease: a systematic review	7
Clinical implications and predictive values of early PASI responses to tildrakizumab in patients with moderate-to-severe plaque psoriasis	7
Deucravacitinib in the treatment of psoriasis	7
Efficacy and safety of dimethylfumarate in elderly psoriasis patients: a multicentric Italian study	7
Probiotics for the prevention of atopic dermatitis in infants from different geographic regions: a systematic review and Meta-analysis	7
A survey-based study of physician practices regarding biotin supplementation	7
Efficacy of intradermal minoxidil 5% injections for treatment of patchy non-severe alopecia areata	7
A time series analysis of immune checkpoint inhibitor use in the United States Medicare population: 2014–2019	7
Assessment of the benefit of achieving complete versus almost complete skin clearance in psoriasis: a patient’s perspective	7
Preliminary results on long-term follow-up of systemic sclerosis patients under extracorporeal photopheresis	7
Drug survival of secukinumab, ustekinumab, and certolizumab pegol in psoriasis: a 2-year, monocentric, retrospective study	7

Unmet needs in atopic dermatitis management: an expert consensus	7
Hyperhidrosis and the risk of being treated for skin infections	7
Clinical management of psoriasis patients during the COVID-19 pandemic	7
Correlation of serum vitamin D levels with severity of pediatric atopic dermatitis and the impact of vitamin D supplementation on treatment outcomes	7
Strategies to maximize clinical efficiency while maintaining patient safety during the COVID-19 pandemic: an interview-based study from private practice dermatologists	7
Managing pediatric psoriasis: update on treatments and challenges—a review	7
Effectiveness of ustekinumab in patients with atopic dermatitis: analysis of real-world evidence	7
Effects of TNF inhibitors and an IL12/23 inhibitor on changes in body weight and adipokine levels in psoriasis patients: a 48-week comparative study	7
Anti-IL-23 and anti-IL-17 drugs for the treatment of non-pustular palmoplantar psoriasis: a real-life retrospective study	7
A clinical perspective on risk factors and signs of subclinical and early psoriatic arthritis among patients with psoriasis	7
Use of systemic therapies for psoriasis in the COVID-19 era	7
Apremilast as a target therapy for nail psoriasis: a real-life observational study proving its efficacy in restoring the nail unit	6
Photo-triage of infantile hemangiomas: potential to reduce healthcare exposure in the COVID19 pandemic	6
Secukinumab retreatment associated psoriasis flare with pustules	6
Eczema control and treatment satisfaction in atopic dermatitis patients treated with dupilumab – a cross-sectional study from the BioDay registry	6
Vitamin D status in patients with autoimmune bullous dermatoses: a meta-analysis	6
Real-world outcomes following switching from anti-TNF reference products to biosimilars for the treatment of psoriasis	6
A qualitative study of dermatology patients and providers to understand discordant perceptions of symptom burden and disease severity	6
Efficacy, safety, usability, and acceptability of risankizumab 150 mg formulation administered by prefilled syringe or by an autoinjector for moderate to severe plaque psoriasis	6
Immunotherapeutic modalities for the treatment of recalcitrant plantar warts: a comparative study	6
Combined chemical peels versus trichloroacetic acid (TCA) for treating melasma: a split face study	6
Dispelling myths about sunscreen	6
Limb melanomas: acral melanomas have worse survival	6
Intralesional immunotherapy for the treatment of anogenital warts in pediatric population	6
Actinomycetoma by Actinomadura madurae. Clinical and therapeutic characteristics of 18 cases with two treatment modalities	6
Isotretinoin for acne vulgaris – an update on adverse effects and laboratory monitoring	6
Autologous plasma gel injection combined with scar subcision is a successful technique for atrophic post-acne scars: a split-face study	6
Maintained improvement in physician- and patient-reported outcomes with baricitinib in adults with moderate-to-severe atopic dermatitis who were treated for up to 104 weeks in a randomized trial	6
Effects of TNF-α inhibition on pre-clinical enthesitis: observational study on 49 psoriatic patients	6
Brodalumab efficacy in bio-naïve psoriasis patients: real-life experience of 202 subjects up to 48 weeks	6
The efficacy and safety of JAK inhibitors for atopic dermatitis: a systematic review and meta-analysis	6
Long-term maintenance treatment of psoriasis: the role of calcipotriol/betamethasone dipropionate aerosol foam in clinical practice	6
A split face comparative study between intradermal tranexamic acid and Erbium-YAG laser in treatment of melasma	6
Real-world evidence for ixekizumab in the treatment of psoriasis and psoriatic arthritis: literature review 2016–2021	6
Outcomes of autologous non-cultured melanocyte keratinocyte transplantation in vitiligo and nevus depigmentosus	6
Neonatal epidermolysis bullosa: lessons to learn about genetic counseling	6